This image is a representation. Your design will be featured in the final product.

Warning: The information provided on this page is for general knowledge purposes only and does not replace the official Instructions for Use (IFU), which are supplied with the medical device. This page does not constitute an electronic IFU either.

Allerpur: allergic rhinitis caused by airborne environmental irritants

ALLERPUR from Vitrobio is a specialized nasal spray designed for the treatment of allergic rhinitis caused by airborne environmental irritants.

This unique formulation contains a blend of natural-origin ingredients, ensuring a high-quality product that is both effective and safe to use.

Clinical trial

Randomized, double-blind, placebo-controlled trial

Population

This product is intended for adult use

Indication

ALLERPUR is indicated for the treatment of mild-to-moderate intermittent allergic rhinitis caused by airborne environmental irritants, in adults.

Patient's Benefits

Reduction of nasal symptoms such as nasal congestion, sneezing, nasal itching and rhinorrhea within 6 days
Reduced nasal congestion from day 1 of treatment
Reduced eye symptoms such as redness, itching and tearing within 6 days
Improvement in quality of life from the reduction of both nasal and ocular symptoms
Reduced need for allergic rhinitis medication
Improved patient well-being and sleep quality
Contributes to the reduction of respiratory symptoms

Mode of action

ALLERPUR stands out with its formula that not only provides quick relief but also offers a long-term solution to allergic rhinitis caused by airborne environmental irritants.

Protective Barrier: It forms a thin, protective film over the mucosa, creating a mechanical barrier that shields it from direct contact with airborne environmental irritants.
Mechanical Cleaning: Utilizes osmotic action to attracts, traps, and removes contaminants, helping to reduce inflammation and alleviate symptoms.
Cellular Repair: Promotes the healing and regeneration of the nasal mucosa, restoring its natural barrier against future allergic triggers.

Clinical Trial

A randomized, double-blind clinical trial (n = 49) confirmed the efficacy of the product in relieving nasal and ocular allergy symptoms over 3 weeks.

The treatment led to a 73% reduction in total nasal symptoms (congestion, rhinorrhea, sneezing, itching) and a 60% reduction in ocular symptoms (redness, tearing, itching) by day 22. Respiratory symptoms (cough, wheezing, chest tightness) also improved by 41%.

A 46% improvement in quality of life was recorded (RQLQ score), and the need for rescue medication was significantly lower in the test group (3.4% vs 23.5% in the placebo group).

These results demonstrate the product’s strong potential to relieve allergic symptoms and improve daily well-being, with excellent tolerability.

Product Details

Indication: Treatment of mild-to-moderate, intermittent, allergic rhinitis caused by environmental irritants.
Composition: Made with ingredients of natural origin
Presentation: Nasal spray 15ml.
Class: MDR Class IIa.
Age: Suitable for adults 18 and over.
Storage conditions: Below 25°C.
Legal manufacturer: VITROBIO (France).
Product code: PC.